🇺🇸 routine dual antiplatelet in United States

routine dual antiplatelet (routine dual antiplatelet) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

routine dual antiplatelet in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is routine dual antiplatelet approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for routine dual antiplatelet in United States?

Shenyang Northern Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.